Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast Early Intervention in Grass Pollinosis
NCT05040828Phase 4Completed
- Sponsor
- Beijing Tongren Hospital
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast in allergic rhinitis (AR), sponsored by Beijing Tongren Hospital. Started Jul 2020; status: completed.
02
Drugs
montelukast
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT05040828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05040828.